Less Ads, More Data, More Tools Register for FREE

Pin to quick picksImage Scan Holdings Regulatory News (IGE)

Share Price Information for Image Scan Holdings (IGE)

Share Price is delayed by 15 minutes
Get Live Data
2.20    0.45 (25.71%)
Bid:
2.10
Ask:
2.30
Spread: 0.20 (9.524%)
Market Cap: £3.01m
IGE Live PriceLast checked at - London Stock Exchange

Intraday Image Scan Holdings Share Chart

Trading Update

27 Feb 2018 07:00

RNS Number : 9716F
Image Scan Holdings PLC
27 February 2018
 

27 February 2018

 

The information contained within this announcement is deemed to constitute inside information as stipulated under the Market Abuse Regulations (EU) No. 596/2014. Upon the publication of this announcement, this inside information is now considered to be in the public domain.

 

Image Scan Holdings plc

("Image Scan" or the "Company")

 

TRADING UPDATE

 

Image Scan, (AIM: IGE) specialists in the field of real-time X-ray imaging for the security and industrial inspection markets, provides a trading update ahead of its Annual General Meeting to be held at 13:30 today.

 

Key Points:

 

· Short term trading impacted by previously reported contract cancellation

· Business trading in line with revised market expectations

· Healthy order pipeline in security and industrial

· Strong interest in portable X-ray systems at Middle East security show

· ThreatScan2® compact precision detector panel to be launched at March exhibition

· Launched integrated back pack system

· New "combi system" with both compact and large format detector panels launched and first orders achieved

· Quality system certified to new international standard

 

On 1 February 2018, the Company announced that it was negotiating cancellation terms for an export order valued at approximately £1m for portable X-ray systems. That process continues and the Board is hopeful this will be resolved before the end of March and that this important customer relationship will remain effective. Some of the units built for the cancelled order have already been repackaged for other customers.

 

The order pipeline for both security and industrial units remains healthy. The Intersec Exhibition in Dubai in January saw strong interest in the product range from the entire region and new orders have been received since the exhibition.

 

Technology from the grant supported Precision Linescan Detector programme is being incorporated into a new range of detector panels, known as ThreatScan2®. The compact version is complete and production has started. The new technology offers a four-fold increase in display resolution compared to the previous range and will compete directly with the more expensive Amorphous Silicon technology used by some competitors. The new panel will be launched at the Security and Counter Terror Exhibition in London's Olympia in March.

 

A new "Combi" system, combining a single generator with both compact and large format panels, a distinctive product in the portable X-ray market, has been designed and first orders have been received. This new system allows bomb technicians to react to the widest possible variety of threat scenarios.

 

The Company's quality management system has been updated and in December 2017, achieved certification against the important new quality standard ISO 9001/2015.

 

The business is trading in line with revised market expectations. As noted in the Company's trading update on 1 February 2018, FY18 sales are expected to be weighted towards the second half. Whilst the Company expects to remain profitable over the full financial year, due to the weighting of sales, the Board expects to report a small loss in the first half.

 

Image Scan's Chairman and Chief Executive, Bill Mawer, commented:

 

"As our product strategy for the Precision Linescan Detector has evolved through the course of the project, I am very pleased to see the results of this program reach the market in our new ThreatScan2® detector panels. Other innovations such as the new Combi system increase the value of individual orders and improve differentiation from our competitors. As stated at the start of the month, the cancellation of any order is disappointing, but I remain confident in the competitiveness of our products and with the future direction of the business."

 

At its Annual General Meeting to be held today at 13:30, the Board will give a brief presentation, a copy of which will shortly be made available on the Company's website www.3dx-ray.com. No new material information will be provided during the presentation.

 

 

-ENDS-

 

For further information, please contact:

 

Image Scan Holdings plc Tel: +44 (0) 1509 817400

William Mawer, Chairman

Sarah Atwell-King, Company Secretary

ir@ish.co.uk

 

Cantor Fitzgerald Europe Tel: +44 (0) 207 894 7000

Rick Thompson / David Foreman (Corporate Finance)

Alex Pollen (Sales)

 

About Image Scan Holdings plc

Image Scan Holdings plc (AIM: IGE) is focused on the development and commercialisation of market leading real-time X-ray solutions for use in the global Security and Industrial inspection markets. The Company's Security portfolio includes the ThreatScan® range of portable bomb and suspect package detection systems; the Axis range of baggage inspection systems; and SVXi, a small vehicle inspection system. The Industrial inspection solutions include the MDXi product range, cabinet X-ray systems for laboratories and production lines. The Company was founded in 1996 and joined AIM in 2002.

 

For further information on the Company, please visit: www.ish.co.uk - and for further information on its products, please visit: www.3dx-ray.com

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
TSTSEEFMMFASELE
Date   Source Headline
5th Jun 20269:45 amRNSContract Award
30th Apr 20267:00 amRNSInterim Results
25th Feb 20262:27 pmRNSResult of AGM
25th Feb 20267:00 amRNSAGM Statement
2nd Feb 20267:00 amRNSUpdate on Defence Contract with NP Aerospace
21st Jan 20261:31 pmRNSNotice of AGM and Posting of Annual Report
2nd Dec 20257:00 amRNSFinal Results
18th Nov 20257:00 amRNS-RContract Award
11th Nov 20257:00 amRNSNew Contract Award
4th Nov 20257:00 amRNSTrading Update
2nd Sep 202511:23 amRNSHolding(s) in Company
21st Aug 20257:00 amRNSTrading Update And New Contract Awards
20th May 20258:32 amRNSInterim Results
14th May 202511:55 amRNSHolding(s) in Company
26th Feb 20252:38 pmRNSResult of AGM
26th Feb 20257:00 amRNSAGM Statement
15th Jan 202510:48 amRNSNotice of AGM & Posting of Annual Report
3rd Dec 20247:00 amRNSFinal Results
23rd Oct 20247:00 amRNSTrading Update
16th Oct 20247:00 amRNSContract Award Update
4th Sep 20247:00 amRNSHolding(s) in Company
21st Aug 20247:00 amRNSHolding(s) in Company
7th Aug 20247:00 amRNSHolding(s) in Company
5th Aug 20247:00 amRNSHolding(s) in Company
24th Jul 20247:00 amRNSHolding(s) in Company
15th Jul 20247:00 amRNSChange of Adviser
4th Jul 20247:00 amRNSContract Award
12th Jun 20247:00 amRNSContract award worth over £350k
20th May 20244:33 pmRNSHolding(s) in Company
30th Apr 20247:00 amRNSInterim Results
29th Apr 20247:00 amRNSInitial c£300k order for new Portable X-Ray System
12th Mar 20247:00 amRNSLaunch of AXIS-CXi Cabinet with AI Software
28th Feb 20242:48 pmRNSResult of AGM
28th Feb 20247:00 amRNSTrading Statement
26th Jan 20241:50 pmRNSHolding(s) in Company
18th Jan 20241:28 pmRNSHolding(s) in Company
11th Jan 20243:06 pmRNSHolding(s) in Company
9th Jan 202412:46 pmRNSNotice of AGM & Posting of Annual Report
9th Jan 202412:00 pmRNSHolding(s) in Company
22nd Dec 20231:30 pmRNSHolding(s) in Company
12th Dec 20237:00 amRNSFinal Results
10th Oct 20237:00 amRNSTrading Update
11th Sep 20237:00 amRNS2023 orders to over 30 countries
4th Jul 20237:00 amRNSHolding(s) in Company
26th Apr 20237:00 amRNSInterim Results
13th Mar 20239:34 amRNSHolding(s) in Company
28th Feb 20233:03 pmRNSResult of AGM
28th Feb 20237:00 amRNSTrading Statement
10th Feb 20231:26 pmRNSHolding(s) in Company
26th Jan 202312:09 pmRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.